(Q40839231)

English

A Phase II study of Bruceantin (NSC-165, 563) in advanced malignant melanoma

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

A Phase II study of Bruceantin (NSC-165, 563) in advanced malignant melanoma (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

author name string

J C Arseneau

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

J M Wolter

2

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

M Kuperminc

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

J C Ruckdeschel

4

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

publication date

1 January 1983

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Investigational New Drugs

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

239-242

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

https://scigraph.springernature.com/pub.10.1007/bf00208896

0 references

Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial clinical studies with bruceantin

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of bruceantin

1 reference

https://pubmed.ncbi.nlm.nih.gov/6678872

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00208896

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40839231&oldid=1908493170"